US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

209.11

-1.1885-0.57%

Volume:2.45M

Turnover:516.22M

Market Cap:503.80B

PE:20.21

High:211.06

Open:209.65

Low:208.93

Close:210.33

52wk High:215.19

52wk Low:140.68

Shares:2.41B

Float Shares:2.40B

Volume Ratio:0.79

T/O Rate:0.10%

Dividend:5.08

Dividend Rate:2.43%

EPS(TTM):10.35

EPS(LYR):5.84

ROE:33.62%

ROA:8.26%

PB:6.35

PE(LYR):35.79

Loading ...

Overview Company News Filings

Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial

Johnson & Johnson Says Tecvayli With Darzalex Faspro Cuts Risk of Death in Multiple Myeloma

MT Newswires Live

BRIEF-Unprecedented Results From The Phase 3 MajesTEC-3 Study Support TECVAYLI Plus DARZALEX FASPRO As A Potential Standard Of Care As Early As Second Line For Patients With Relapsed/Refractory Multiple Myeloma

FDA Reviews Johnson & Johnson's TECVAYLI and DARZALEX FASPRO Combination for Multiple Myeloma

J&J - Tecvayli and Darzalex Show Significant Survival Advantage

THOMSON REUTERS

J&J - Submits Sbla for Tecvayli and Darzalex Combination as Treatment for Rrmm

THOMSON REUTERS

Unprecedented Results From the Phase 3 Majestec-3 Study Support Tecvayli® Plus Darzalex Faspro® as a Potential Standard of Care as Early as Second Line for Patients With Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

Perrigo Co. PLC Stock Underperforms Monday When Compared To Competitors

Johnson & Johnson to Present at J.P. Morgan Healthcare Conference

Eli Lilly, Pfizer Feature in China's Commercial Insurance Innovative Drug Catalog

MT Newswires Live

Eli Lilly (LLY.US), Johnson & Johnson (JNJ.US), and Pfizer (PFE.US) Expand in China: Innovative Drugs Included in First Commercial Insurance List

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

Johnson & Johnson Reports CARVYKTI Achieves 80% Treatment-Free Remission at 2.5 Years in Multiple Myeloma Trial

Johnson & Johnson Posts 74% One-Year Disease-Free Survival Rate in INLEXZO Trial

MT Newswires Live

Johnson & Johnson Reports Positive Results for Gemcitabine Intravesical System in High-Risk NMIBC Trial

Johnson & Johnson's Inlexzo™ (Gemcitabine Intravesical System) Delivers 74 Percent Disease-Free Survival at One Year in Bcg-Unresponsive, High-Risk, Papillary-Only Nmibc

THOMSON REUTERS

Johnson & Johnson Is Maintained at Buy by Guggenheim

Guggenheim Adjusts Price Target on Johnson & Johnson to $227 From $206, Maintains Buy Rating

MT Newswires Live

Perrigo Co. PLC Stock Underperforms Tuesday When Compared To Competitors

Johnson & Johnson wins European Commission approval for IMAAVY (nipocalimab) in generalized myasthenia gravis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JNJ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":209.1415,"timestamp":1766076611235,"preClose":210.33,"halted":0,"volume":2454240,"delay":0,"floatShares":2404573193,"shares":2409295102,"eps":10.347906,"marketStatus":"Trading","change":-1.1885,"latestTime":"12-18 11:50:11 EST","open":209.65,"high":211.06,"low":208.93,"amount":516220423.968,"amplitude":0.010127,"askPrice":209.17,"askSize":70,"bidPrice":209.06,"bidSize":20,"shortable":3,"etf":0,"ttmEps":10.347906,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766091600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":210.33,"dividendRate":0.02429,"preHourTrading":{"tag":"盘前","latestPrice":209.01,"preClose":210.33,"latestTime":"09:29 EST","volume":3228,"amount":677276.71908,"timestamp":1766068187070},"postHourTrading":{"tag":"盘后","latestPrice":210.47,"preClose":210.33,"latestTime":"19:58 EST","volume":760016,"amount":159854883.425401,"timestamp":1766019502215},"volumeRatio":0.792918,"impliedVol":0.2117,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2404573193,"roa":"8.26%","roe":"33.62%","lyrEps":5.84306,"volumeRatio":0.792835,"shares":2409295102,"dividePrice":5.08,"high":211.06,"amplitude":0.010127,"preClose":210.33,"low":208.93,"week52Low":140.68,"pbRate":"6.35","psRate":"5.47","week52High":215.185,"institutionHeld":0.6556,"latestPrice":209.1065,"committee":-0.555556,"eps":10.347906,"divideRate":0.024294,"volume":2453983,"delay":0,"ttmEps":10.347906,"open":209.65,"prevYearClose":144.62,"prevWeekClose":211.58,"prevMonthClose":206.92,"prevQuarterClose":185.42,"fiveDayClose":210.01,"twentyDayClose":202.51,"sixtyDayClose":176.69,"dividendPayoutRate":0.8403131236030436,"dividendFrequency":"Q","dividendGrowthYears":9,"dividendGrowthRate":0.044680851063829775,"fiveYearAvgDividendRate":0.02776188459972511},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2026-01-21","symbol":"JNJ","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":2.53,"defaultRemindTime":1768986000000,"name":null,"time":"Pre-Market","dateTimestamp":1768971600000,"actualEps":null},{"date":"2025-11-25","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-25","defaultRemindTime":1764081000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-09","payableDate":"2025-11-25","currency":"USD","dateTimestamp":1764046800000,"payDate":"2025-12-09"},{"market":"US","date":"2025-10-14","symbol":"JNJ","fiscalQuarterEnding":"2025/09","expectedEps":2.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1760414400000,"reportTimeType":"pre","actualEps":2.8},{"date":"2025-08-26","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-26","defaultRemindTime":1756215000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-08-26","currency":"USD","dateTimestamp":1756180800000,"payDate":"2025-09-09"},{"market":"US","date":"2025-07-16","symbol":"JNJ","fiscalQuarterEnding":"2025/06","expectedEps":2.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752638400000,"reportTimeType":"pre","actualEps":2.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-19","recordDate":"2016-02-23","paymentDate":"2016-03-08","value":0.75,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"},{"executeDate":"2016-08-19","recordDate":"2016-08-23","paymentDate":"2016-09-06","value":0.8,"currency":"USD"},{"executeDate":"2016-11-18","recordDate":"2016-11-22","paymentDate":"2016-12-06","value":0.8,"currency":"USD"},{"executeDate":"2017-02-24","recordDate":"2017-02-28","paymentDate":"2017-03-14","value":0.8,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1786,"buy":0.3571,"hold":0.4643,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3571,"analysts":28,"updateTime":1765947600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2025-12-17","current":20.325851,"percent":0.321667,"low":8.579006,"twenty":16.872299,"median":23.669149,"eighty":27.89845,"high":36.412821,"avg":21.980263,"sd":6.87228,"marketCap":504265464848},"quantilePoints":[{"date":"2020-12-18","current":23.946436,"twenty":21.042546,"median":23.534826,"eighty":27.599044,"marketCap":406754168250},{"date":"2020-12-24","current":23.630271,"twenty":21.070826,"median":23.548153,"eighty":27.599044,"marketCap":401383781199},{"date":"2020-12-31","current":24.391238,"twenty":21.097347,"median":23.558663,"eighty":27.599044,"marketCap":414309565719},{"date":"2021-01-08","current":24.803493,"twenty":21.111621,"median":23.586469,"eighty":27.599044,"marketCap":421312129226},{"date":"2021-01-15","current":24.843788,"twenty":21.147258,"median":23.595957,"eighty":27.599044,"marketCap":421996590321},{"date":"2021-01-22","current":25.347483,"twenty":21.183404,"median":23.599747,"eighty":27.599044,"marketCap":430552354005},{"date":"2021-01-29","current":29.186264,"twenty":21.19897,"median":23.614272,"eighty":30.081908,"marketCap":429446686083},{"date":"2021-02-05","current":29.422431,"twenty":21.226117,"median":23.637028,"eighty":30.081908,"marketCap":432921642410},{"date":"2021-02-12","current":29.803518,"twenty":21.248794,"median":23.655744,"eighty":30.081908,"marketCap":438528958301},{"date":"2021-02-19","current":29.159427,"twenty":21.257145,"median":23.669632,"eighty":30.081908,"marketCap":429051804682},{"date":"2021-02-26","current":28.309134,"twenty":21.271585,"median":23.6918,"eighty":30.081908,"marketCap":416540604911},{"date":"2021-03-05","current":27.887517,"twenty":21.285637,"median":23.70506,"eighty":30.12771,"marketCap":410336920526},{"date":"2021-03-12","current":28.556475,"twenty":21.311821,"median":23.72791,"eighty":30.12771,"marketCap":420179968572},{"date":"2021-03-19","current":28.635202,"twenty":21.329473,"median":23.741859,"eighty":30.12771,"marketCap":421338359462},{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115},{"date":"2025-05-02","current":17.039985,"twenty":20.756324,"median":23.911734,"eighty":27.898419,"marketCap":371642078674},{"date":"2025-05-09","current":17.172369,"twenty":19.990901,"median":23.911734,"eighty":27.898419,"marketCap":374529366609},{"date":"2025-05-16","current":16.504935,"twenty":17.262967,"median":23.911734,"eighty":27.898419,"marketCap":359972623271},{"date":"2025-05-23","current":16.835894,"twenty":17.138832,"median":23.911734,"eighty":27.898419,"marketCap":367190843108},{"date":"2025-05-30","current":16.942904,"twenty":17.043515,"median":23.911734,"eighty":27.898419,"marketCap":369524734188},{"date":"2025-06-06","current":16.951729,"twenty":17.017922,"median":23.911734,"eighty":27.898419,"marketCap":369717220051},{"date":"2025-06-13","current":17.282689,"twenty":17.017922,"median":23.911734,"eighty":27.898419,"marketCap":376935439888},{"date":"2025-06-20","current":16.628493,"twenty":17.004683,"median":23.912184,"eighty":27.89845,"marketCap":362667425343},{"date":"2025-06-27","current":16.769702,"twenty":16.906498,"median":23.912184,"eighty":27.89845,"marketCap":365747199140},{"date":"2025-07-03","current":17.210981,"twenty":16.898776,"median":23.912184,"eighty":27.89845,"marketCap":375371492256},{"date":"2025-07-11","current":17.396318,"twenty":16.898776,"median":23.912184,"eighty":27.89845,"marketCap":379413695365},{"date":"2025-07-18","current":17.304701,"twenty":16.872299,"median":23.905255,"eighty":27.89845,"marketCap":392141823011},{"date":"2025-07-25","current":18.020297,"twenty":16.872299,"median":23.873915,"eighty":27.89845,"marketCap":408357939136},{"date":"2025-08-01","current":17.508042,"twenty":16.872299,"median":23.864311,"eighty":27.89845,"marketCap":396749745773},{"date":"2025-08-08","current":18.229662,"twenty":16.872299,"median":23.835219,"eighty":27.89845,"marketCap":413102366714},{"date":"2025-08-15","current":18.568685,"twenty":16.872299,"median":23.814665,"eighty":27.89845,"marketCap":420784967715},{"date":"2025-08-22","current":19.01611,"twenty":16.872299,"median":23.808501,"eighty":27.89845,"marketCap":430924074366},{"date":"2025-08-29","current":18.646267,"twenty":16.872299,"median":23.782296,"eighty":27.89845,"marketCap":422543055092},{"date":"2025-09-05","current":18.998043,"twenty":16.868107,"median":23.745347,"eighty":27.900551,"marketCap":430514656758},{"date":"2025-09-12","current":18.970411,"twenty":16.872299,"median":23.733548,"eighty":27.89845,"marketCap":429888488652},{"date":"2025-09-19","current":18.50917,"twenty":16.872299,"median":23.723009,"eighty":27.89845,"marketCap":419436297947},{"date":"2025-09-26","current":18.888578,"twenty":16.872299,"median":23.712233,"eighty":27.89845,"marketCap":428034067720},{"date":"2025-10-03","current":19.765362,"twenty":16.872299,"median":23.703561,"eighty":27.89845,"marketCap":447902863414},{"date":"2025-10-10","current":20.307374,"twenty":16.872299,"median":23.676362,"eighty":27.89845,"marketCap":460185391661},{"date":"2025-10-17","current":18.419924,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":462690064088},{"date":"2025-10-24","current":18.422041,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":462743240559},{"date":"2025-10-31","current":18.132778,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":455477239033},{"date":"2025-11-07","current":17.933274,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":450465905220},{"date":"2025-11-14","current":18.727452,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":470414868665},{"date":"2025-11-21","current":19.477509,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":489255556363},{"date":"2025-11-28","current":19.846783,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":498531342505},{"date":"2025-12-05","current":19.420919,"twenty":16.872299,"median":23.673244,"eighty":27.89845,"marketCap":487834072252},{"date":"2025-12-12","current":20.143161,"twenty":16.872299,"median":23.669149,"eighty":27.89845,"marketCap":505976064371},{"date":"2025-12-17","current":20.075061,"twenty":16.872299,"median":23.669149,"eighty":27.89845,"marketCap":504265464848}],"updateTime":1766050328710},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590323374","title":"Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590323374","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590323374?lang=en_us&edition=fundamental","pubTime":"2025-12-10 00:39","pubTimestamp":1765298340,"startTime":"0","endTime":"0","summary":"Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its burixafor combination in multiple myeloma.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/09/Molecule-Of-Dna-Forming-Inside-The-Test-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/09/Molecule-Of-Dna-Forming-Inside-The-Test-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49284762/exicure-rally-fueled-by-rapid-cell-boosting-results-in-blood-cancer-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49284762/exicure-rally-fueled-by-rapid-cell-boosting-results-in-blood-cancer-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU0889566641.SGD","SG9999002224.SGD","LU1894683264.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","IE0034235303.USD","IE0002270589.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1894683348.USD","LU0345770308.USD","BK4581","LU1506573853.SGD","LU1244550494.USD","LU2089984988.USD","IE00B19Z3581.USD","LU1280957306.USD","IE00B1BXHZ80.USD","LU1267930813.SGD","LU1061106388.HKD","BK4007","JNJ","IE00BKVL7J92.USD","LU2129689514.USD","LU2468319806.SGD","XCUR","LU0289739699.SGD","LU0345770993.USD","IE0002141913.USD","LU2750360641.GBP","LU1935042991.SGD","IE00B4R5TH58.HKD","LU1674673691.USD","IE0009355771.USD","IE00BSNM7G36.USD","BK4588","LU2129689605.HKD","IE00B2B36J28.USD","IE00B3T34201.USD","LU0098860793.USD","LU1066051225.USD","LU1057294990.SGD","LU1196500208.SGD","LU0203345920.USD","LU0432979614.USD","SG9999002232.USD","LU1585245621.USD","SG9999001440.SGD","LU1059921491.USD"],"gpt_icon":0},{"id":"2590150347","title":"Johnson & Johnson Says Tecvayli With Darzalex Faspro Cuts Risk of Death in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590150347","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590150347?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:09","pubTimestamp":1765292997,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  said Tuesday that new data from a phase 3 study showed the combination of Tecvayli and Darzalex Faspro cut the risk of disease progression or death by 83% in patients with relapsed or refractory multiple myeloma at almost three years of follow-up.The company said the trial showed that 91% of patients who were progression-free at six months remained progression-free at three years.The company also said the Tecvayli combination achieved higher rates across key secondary endpoints, including overall response, complete response, minimal residual disease negativity and overall survival, compared with standard of care. At three years, overall survival rate was 83.3% for the Tecvayli combination, Johnson & Johnson said.The study compared Tecvayli plus Darzalex Faspro with combinations of Darzalex Faspro and dexamethasone with either pomalidomide or bortezomib in patients previously treated with one to three lines of therapy, according to the company.Johnson & Johnson said i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889566641.SGD","LU1066051225.USD","LU0203345920.USD","IE0034235303.USD","LU1032955483.USD","LU2347655156.SGD","IE00BSNM7G36.USD","BK4534","LU1162221912.USD","BK4559","LU2471134952.CNY","LU0114720955.EUR","LU2471134879.HKD","LU1066051498.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","BK4588","LU0640476718.USD","IE00BN8TJ469.HKD","LU2089984988.USD","LU2430703178.SGD","IE00BVYPNW00.USD","LU0122379950.USD","LU0792757196.USD","IE00B42XCP33.USD","IE00BDGV0183.EUR","JNJ","SG9999002224.SGD","LU0345770993.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU0234572021.USD","LU0795875086.SGD","LU1066051811.HKD","BK4585","LU0289739699.SGD","LU0345770308.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","LU1244550221.USD","LU2468319806.SGD","LU1280957306.USD","BK4581","LU1894683264.USD","LU0912757837.SGD","LU0882574055.USD","LU1674673691.USD","LU1894683348.USD","LU1267930813.SGD","LU1032466523.USD"],"gpt_icon":0},{"id":"2590346947","title":"BRIEF-Unprecedented Results From The Phase 3 MajesTEC-3 Study Support TECVAYLI Plus DARZALEX FASPRO As A Potential Standard Of Care As Early As Second Line For Patients With Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346947","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346947?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:47","pubTimestamp":1765284428,"startTime":"0","endTime":"0","summary":"BRIEF-Unprecedented Results From The Phase 3 MajesTEC-3 Study Support TECVAYLI Plus DARZALEX FASPRO As A Potential Standard Of Care As Early As Second Line For Patients With Relapsed/Refractory Multip","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUACBKTCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875086.SGD","LU1929549753.HKD","LU1221951046.USD","IE00B42XCP33.USD","LU0345770993.USD","IE000M9KFDE8.USD","LU1066051811.HKD","LU0345769631.USD","BK4534","BK4533","LU1221951129.SGD","BK4532","BK4592","LU1244550577.SGD","LU2750360997.AUD","LU0882574055.USD","LU1718418525.SGD","LU2471134879.HKD","IE00BKVL7J92.USD","IE00BFTCPJ56.SGD","LU0792757196.USD","LU1244550494.USD","IE00B3PB1722.GBP","LU0320765646.SGD","LU2471134796.USD","JNJ","LU0234570918.USD","LU1023059063.AUD","LU2750360641.GBP","LU0058720904.USD","LU0289739699.SGD","SG9999001440.SGD","LU2468319806.SGD","LU2471134952.CNY","LU1732800096.USD","LU0345769128.USD","IE00B19Z3B42.SGD","LU0070217475.USD","LU1267930813.SGD","BK4568","LU0345770308.USD","SG9999002224.SGD","LU2471134523.USD","LU0234572021.USD","LU1066051498.USD","LU2133065610.SGD","IE00B19Z3581.USD","BK4504","LU2112291526.USD","BK4581"],"gpt_icon":0},{"id":"2590346641","title":"FDA Reviews Johnson & Johnson's TECVAYLI and DARZALEX FASPRO Combination for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346641","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346641?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:44","pubTimestamp":1765284286,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via PR Newswire  on December 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL1H3dvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875086.SGD","LU1585245621.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0345770993.USD","LU1244550221.USD","LU1894683348.USD","IE00BSNM7G36.USD","LU0345769631.USD","LU0640476718.USD","LU1221951129.SGD","LU2750360997.AUD","LU0203345920.USD","IE00B3T34201.USD","BK4585","IE00BGHQF631.EUR","LU1718418525.SGD","LU1059921491.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","IE00BVYPNW00.USD","LU1066051225.USD","LU2430703095.HKD","LU2505996681.GBP","LU2471134796.USD","JNJ","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4007","SG9999001440.SGD","LU2468319806.SGD","LU2471134952.CNY","IE00BVYPNV92.GBP","LU1732800096.USD","LU0070217475.USD","IE00BFXG1179.USD","BK4568","LU1074936037.SGD","SG9999002224.SGD","LU1032466523.USD","LU2471134523.USD","LU1066051498.USD","LU1430594728.SGD","IE0002270589.USD","LU2133065610.SGD","IE00B19Z3581.USD","LU2112291526.USD","LU1244550577.SGD","LU1496350502.SGD"],"gpt_icon":0},{"id":"2590466943","title":"J&J - Tecvayli and Darzalex Show Significant Survival Advantage","url":"https://stock-news.laohu8.com/highlight/detail?id=2590466943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590466943?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:44","pubTimestamp":1765284267,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUACBKTCY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765646.SGD","IE00BFTCPJ56.SGD","BK4532","LU0345769128.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0345770993.USD","IE00B3PB1722.GBP","LU2471134796.USD","LU2471134952.CNY","IE00B19Z3581.USD","LU1066051811.HKD","LU1732800096.USD","LU2471134523.USD","LU0289739699.SGD","BK4533","LU0070217475.USD","LU1267930813.SGD","LU2750360641.GBP","BK4504","LU2133065610.SGD","LU1244550494.USD","LU1221951129.SGD","LU1244550577.SGD","LU1929549753.HKD","IE00B42XCP33.USD","JNJ","SG9999001440.SGD","BK4568","LU1221951046.USD","LU2750360997.AUD","LU1718418525.SGD","IE000M9KFDE8.USD","BK4592","LU0234572021.USD","LU0234570918.USD","LU0345770308.USD","BK4581","LU2468319806.SGD","LU0882574055.USD","LU0792757196.USD","LU0058720904.USD","LU2112291526.USD","LU0795875086.SGD","LU1066051498.USD","LU0345769631.USD","IE00BKVL7J92.USD","BK4534","LU2471134879.HKD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2590346917","title":"J&J - Submits Sbla for Tecvayli and Darzalex Combination as Treatment for Rrmm","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346917?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:44","pubTimestamp":1765284267,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUACBKTCY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0345770308.USD","JNJ","IE00BKVL7J92.USD","BK4585","LU1057294990.SGD","LU1261432733.SGD","IE00B7SZLL34.SGD","LU2129689514.USD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","BK4568","LU0114720955.EUR","IE00B3T34201.USD","IE0034235303.USD","LU0345770993.USD","IE0002141913.USD","LU1066051498.USD","LU2129689605.HKD","LU1196500208.SGD","IE00BFXG1179.USD","LU0985320562.USD","LU1894683348.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU0466842654.USD","LU0640476718.USD","LU2468319806.SGD","LU2750360997.AUD","LU0889566641.SGD","IE00BDGV0183.EUR","LU1066053197.SGD","LU1059921491.USD","IE00BN8TJ469.HKD","LU1280957306.USD","LU1032466523.USD","BK4007","LU0912757837.SGD","LU0289739699.SGD","LU1732800096.USD","IE00B1BXHZ80.USD","LU1162221912.USD","LU1061106388.HKD","LU2347655156.SGD","LU1506573853.SGD","IE00BLSP4239.USD","LU0792757196.USD","LU0345769631.USD","LU2089984988.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2590346691","title":"Unprecedented Results From the Phase 3 Majestec-3 Study Support Tecvayli® Plus Darzalex Faspro® as a Potential Standard of Care as Early as Second Line for Patients With Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346691?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:44","pubTimestamp":1765284267,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUACBKTCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4592","LU2750360997.AUD","LU0114720955.EUR","LU1162221912.USD","JNJ","IE00BFXG1179.USD","LU0289739699.SGD","LU2468319806.SGD","IE0034235303.USD","LU1196500208.SGD","LU0792757196.USD","LU1057294990.SGD","IE00BDGV0183.EUR","IE00BLSP4239.USD","IE00B4R5TH58.HKD","BK4007","LU0345770993.USD","IE00BJT1NW94.SGD","LU2347655156.SGD","LU0912757837.SGD","LU1066051498.USD","BK4568","IE0002141913.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4585","BK4504","LU1059921491.USD","LU0466842654.USD","LU1032466523.USD","LU1732800096.USD","LU2129689514.USD","IE00BVYPNV92.GBP","IE00BBT3K403.USD","LU0985320562.USD","LU1061106388.HKD","LU1894683348.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0640476718.USD","SG9999001440.SGD","LU1506573853.SGD","LU1280957306.USD","IE00BJJMRZ35.SGD","LU0889566641.SGD","IE00BN8TJ469.HKD","LU2129689605.HKD","LU0345770308.USD","IE00B1BXHZ80.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2590369042","title":"Perrigo Co. PLC Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590369042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590369042?lang=en_us&edition=fundamental","pubTime":"2025-12-09 06:30","pubTimestamp":1765233000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  shed 2.68% to $13.08 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32.This was the stock's third consecutive day of losses.Perrigo Co. PLC closed 57.71% short of its 52-week high of $30.93, which the company achieved on March 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.15% to $201.62, Procter & Gamble Co.  fell 3.56% to $138.34, and Abbott Laboratories  fell 2.39% to $122.09.Trading volume  eclipsed its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones N","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0098860793.USD","LU1778281490.HKD","SG9999014575.USD","LU0114720955.EUR","PG","IE00B42XCP33.USD","IE00BGHQF631.EUR","IE00B19Z3B42.SGD","LU1506573853.SGD","LU2347655156.SGD","BK4007","BK4592","LU2471134879.HKD","LU0345769128.USD","LU2471134523.USD","LU2237957811.SGD","LU1280957306.USD","LU1691799644.USD","IE00B1XK9C88.USD","LU0889566641.SGD","IE00B3PB1722.GBP","IE00B3T34201.USD","IE00BFXG1179.USD","LU0942090050.USD","LU1221951046.USD","LU2129689605.HKD","LU2750360641.GBP","ABT","IE00B7SZLL34.SGD","LU0289739699.SGD","LU2471134796.USD","JNJ","LU1066051498.USD","IE0002141913.USD","LU0345769631.USD","LU1032466523.USD","PRGO","LU0061475181.USD","SGXZ23171101.USD","BK4568","BK4588","LU1732800096.USD","LU0345770993.USD","LU1057294990.SGD","LU2471134952.CNY","LU2237957902.USD","LU0070217475.USD","LU1221951129.SGD"],"gpt_icon":0},{"id":"2590026365","title":"Johnson & Johnson to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2590026365","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590026365?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:24","pubTimestamp":1765229072,"startTime":"0","endTime":"0","summary":"Johnson & Johnson will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Company management is scheduled to join a Fireside Chat at 11:15 a.m. Eastern Time, with a live audio webcast available on Johnson & Johnson's Investor Relations website. An archived edition of the session will be accessible later the same day.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL4ngFfG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","LU0058720904.USD","LU0889566641.SGD","LU1196500208.SGD","IE00B3PB1722.GBP","LU0640476718.USD","LU0792757196.USD","LU1280957306.USD","LU2471134952.CNY","LU2129689431.USD","BK4592","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","LU1894683348.USD","IE00BJT1NW94.SGD","LU2592432038.USD","LU0882574055.USD","LU2129689514.USD","LU0795875086.SGD","LU0795875169.SGD","IE00BGHQF631.EUR","IE00B19Z3581.USD","JNJ","BK4568","IE00B3T34201.USD","LU1506573853.SGD","LU1935042991.SGD","LU0432979614.USD","LU1221951129.SGD","LU2602419157.SGD","LU1066053197.SGD","LU2430703178.SGD","IE00BLSP4452.SGD","LU1778281490.HKD","BK4533","LU0345769631.USD","LU1914381329.SGD","BK4532","IE00B42XCP33.USD","IE00B7SZLL34.SGD","LU0345770308.USD","LU0122379950.USD","IE00BDGV0183.EUR","LU1061106388.HKD","LU2505996509.AUD","IE00BFXG1179.USD","LU2471134879.HKD","IE00B2B36J28.USD","BK4588","LU1059921491.USD"],"gpt_icon":0},{"id":"2589995332","title":"Eli Lilly, Pfizer Feature in China's Commercial Insurance Innovative Drug Catalog","url":"https://stock-news.laohu8.com/highlight/detail?id=2589995332","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589995332?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:24","pubTimestamp":1765193085,"startTime":"0","endTime":"0","summary":"Eli Lilly  and Pfizer  are among the major pharmaceutical companies featured in China's commercial insurance innovative drug catalog, the National Healthcare Security Administration said Sunday.The catalog included 19 drugs for the treatment of cancer, Alzheimer's disease, and other diseases.Johnson & Johnson  and Bristol-Myers Squibb  also featured on the list.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0096364046.USD","LU0471298694.HKD","LU0354030511.USD","IE00B4JS1V06.HKD","IE0004445015.USD","BMY","IE00B775H168.HKD","LU1929549753.HKD","LU2471134523.USD","LU1066051498.USD","LU2491050154.USD","IE00B7SZLL34.SGD","LU2417539215.USD","LU2236285917.USD","LU0289739699.SGD","LU2552382132.HKD","LU0238689110.USD","LU0795875169.SGD","LU0820561818.USD","LU1267930813.SGD","LU0323591593.USD","LU0306807586.USD","BK4532","LU0889566641.SGD","LU1868837300.USD","LU1868837136.USD","LU1093756325.SGD","BK4599","LU0058720904.USD","LU0321505439.SGD","LU0266013472.USD","LU1670711123.USD","LU2750360997.AUD","JNJ","LU1066051225.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU1221951129.SGD","LU0320765992.SGD","LU1894683348.USD","SGXZ31699556.SGD","LU1232071149.USD","LU1551013342.USD","LU0882574055.USD","LU1366192091.USD","LU1571399168.USD","LU2602419157.SGD","LU2592432038.USD","BK4516","LU0385154629.USD","SG9999015986.USD","LU0070217475.USD","LU0345770308.USD","LU0786609619.USD","IE00BFSS7M15.SGD","LU1712237335.SGD","LU0672654240.SGD","LU0198837287.USD","LU2491050071.SGD","LU0466842654.USD","LU0321505868.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2471134952.CNY","IE00B42XCP33.USD","BK4581","LU2505996509.AUD","LU2023250504.SGD","IE00BJT1NW94.SGD","LU0203202063.USD","LU2456880835.USD","IE00BKPKM429.USD","BK4533","LU0868494617.USD","IE00BSNM7G36.USD","LU1059921491.USD","LU1430594728.SGD","LU0912757837.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0256863811.USD","LU1814569148.SGD","LU1093756168.USD","LU2750360641.GBP","IE00BZ1G4Q59.USD","PFE","IE00BFSS8Q28.SGD","LU2242646821.SGD","SG9999018865.SGD","BK4504","LU0109394709.USD","LU1032466523.USD","LU0098860793.USD","LU1066051811.HKD","LU0689472784.USD","IE00BLSP4452.SGD","LU1280957306.USD","LU1291159041.SGD","LU0234572021.USD","LU2133065610.SGD","LU0114720955.EUR","LU0234570918.USD","LU2237443382.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0237698245.USD","IE00BFXG1179.USD","LU1066053197.SGD","LU2237443465.HKD","IE00BKVL7J92.USD","IE0005OL40V9.USD","LU2237443549.SGD","LU1064131342.USD","IE0004445239.USD","LU1720051108.HKD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","SG9999014880.SGD","IE00BDGV0183.EUR","IE00BN29S564.USD","LU1244550577.SGD","LU1057294990.SGD","LU1267930730.SGD","IE00BGHQF631.EUR","LU0345769128.USD","IE00BVYPNW00.USD","LU0079474960.USD","IE00BKDWB100.SGD","LU0985481810.HKD","LLY","IE00B19Z3B42.SGD","BK4592","LU1506573853.SGD","LU1127390331.HKD","LU0225284248.USD","LU1868836914.USD","LU0823416689.USD","LU0823434740.USD","LU0471298777.SGD","LU1935042991.SGD","IE00B3PB1722.GBP","LU0320765646.SGD","SG9999018857.SGD","LU0094547139.USD","LU1868836757.USD","LU0203347892.USD","LU0320765059.SGD","LU2265009873.SGD","LU0203345920.USD","LU1032955483.USD","LU0225771236.USD","LU0267386448.USD","BK4588","LU1974910355.USD","LU2347655156.SGD","LU2360106947.USD","LU0061475181.USD","SG9999003800.SGD","LU0306806265.USD","LU1732799900.SGD","LU2129689605.HKD","LU2168564065.EUR","IE00BJLML261.HKD","LU0820561909.HKD","SGXZ57979304.SGD","LU2168564149.EUR","LU0889565916.HKD","LU2125154778.USD","LU2129689431.USD","LU2462157665.USD","BK4550","SG9999015978.USD","SGXZ81514606.USD","LU1074936037.SGD","LU2461242641.AUD","LU0823434583.USD","LU0432979614.USD","LU2552382058.USD","IE00BK4W5M84.HKD","LU2430703095.HKD","LU1196500208.SGD","LU2129689514.USD","LU2237443895.HKD","LU0203201768.USD","LU2430703178.SGD","LU2552382215.SGD","SG9999002232.USD","LU1670710588.SGD","SG9999001176.USD","BK4559","LU2168563687.JPY","LU0456855351.SGD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU2360032135.SGD","IE00BWXC8680.SGD","BK4007","LU2468319806.SGD","LU0345769631.USD","LU0417517546.SGD","LU1035775433.USD","LU1670710661.SGD","LU1720051017.SGD","LU2106854487.HKD","LU2361044949.HKD","SG9999015945.SGD","LU1988902786.USD","IE00B2B36J28.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU1162221912.USD","IE0034235303.USD","GB00BDT5M118.USD","LU1917777945.USD","LU1914381329.SGD","LU1623119135.USD","LU1261432733.SGD","LU0316494557.USD","LU1804176565.USD","LU1496350502.SGD","LU0353189763.USD","LU2430703251.USD","LU2357305700.SGD","LU2112291526.USD","SGXZ51526630.SGD","LU1244550494.USD","LU1023059063.AUD","LU0792757196.USD","BK4585","LU1551013425.SGD","LU1061106388.HKD","LU1883839398.USD","SG9999002224.SGD","LU1989771016.USD","BK4534","SG9999001176.SGD","LU2491049909.HKD","BK4568","LU2505996681.GBP","LU1221951046.USD","LU2746668461.USD","SG9999013999.USD","SG9999001440.SGD","LU2168564495.EUR","IE0002270589.USD","IE00BVYPNV92.GBP","IE00B7KXQ091.USD","LU2324357040.USD","LU1585245621.USD","SGXZ99366536.SGD","LU0256863902.USD","LU0122379950.USD","LU2089984988.USD","LU0943347566.SGD","LU0985320562.USD","IE00BLSP4239.USD","LU1548497426.USD","BK7095","LU1674673691.USD","SG9999014914.USD","LU2264538146.SGD","LU0109391861.USD","LU1778281490.HKD","IE00BBT3K403.USD","IE00BJJMRY28.SGD","LU0170899867.USD","LU0795875086.SGD","LU2168564222.USD","LU1718418525.SGD","LU2242652126.USD","LU2361045086.USD","LU0354030438.USD","LU2211815571.USD","LU1244550221.USD","LU2125154935.USD","LU1670711040.USD","LU2063271972.USD","LU2237438978.USD","LU1674673428.USD","SG9999011175.SGD","LU2087625088.SGD","LU0345770993.USD","LU0353189680.USD","LU1732800096.USD","LU0882574139.USD","LU2237443622.USD","LU2746668974.SGD","IE00B1XK9C88.USD","LU1323610961.USD","LU0097036916.USD","LU0640476718.USD","LU1069344957.HKD","LU1894683264.USD","SG9999014906.USD","SG9999017495.SGD","IE0009355771.USD","LU0106261372.USD","LU2361044865.SGD","SG9999014898.SGD","IE0002141913.USD","LU1868836591.USD","IE00BJJMRX11.SGD","SG9999015952.SGD","IE00B3T34201.USD","LU2471134796.USD"],"gpt_icon":0},{"id":"1148490400","title":"Eli Lilly (LLY.US), Johnson & Johnson (JNJ.US), and Pfizer (PFE.US) Expand in China: Innovative Drugs Included in First Commercial Insurance List","url":"https://stock-news.laohu8.com/highlight/detail?id=1148490400","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148490400?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:20","pubTimestamp":1765167621,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY.US), Pfizer (PFE.US), and Johnson & Johnson (JNJ.US) have secured positions in China's first innovative drug catalog, opening new market channels and boosting sales prospects for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0353189680.USD","LU1291159041.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","BK4599","LU0320765992.SGD","LU0823434583.USD","IE0004445239.USD","MCHI","SGXZ51526630.SGD","LU0708995401.HKD","LU2168564065.EUR","LU0985320562.USD","LU1280957306.USD","BK1574","LU2360106947.USD","IE00B4JS1V06.HKD","LU0321505439.SGD","IE00BVYPNV92.GBP","LU0079474960.USD","LU0109391861.USD","LU1057294990.SGD","LU2106854487.HKD","LU2168564222.USD","LU2237443549.SGD","LU2265009873.SGD","LU2471134523.USD","LU2471134952.CNY","LU1244550577.SGD","LU2750360997.AUD","LU2112291526.USD","IE00BK4W5M84.HKD","IE00BLSP4452.SGD","LU0823434740.USD","LU1093756168.USD","LU2237443382.USD","IE00B2B36J28.USD","BK4588","LU0256863811.USD","LU0203201768.USD","LU1720051017.SGD","IE0002141913.USD","IE0009355771.USD","IE00BJJMRX11.SGD","LU2168563687.JPY","LU0122379950.USD","LU0320765646.SGD","LU2361044949.HKD","LU2461242641.AUD","LU1929549753.HKD","LU0432979614.USD","LU0466842654.USD","LU2491050154.USD","LU0256863902.USD","LU0345769631.USD","IE00BGHQF631.EUR","IE00BK4W5L77.USD","SG9999013999.USD","BK4568","FXI","IE00BVYPNW00.USD","PFE","IE00BBT3K403.USD","LU0070217475.USD","LU2168564495.EUR","LU2505996681.GBP","LU1061106388.HKD","SG9999011175.SGD","LU1868836591.USD","LU2471134796.USD","LU1066051225.USD","LU0471298694.HKD","LU1244550494.USD","LU1221951046.USD","LU0321505868.SGD","LU0985481810.HKD","LU1718418525.SGD","LU1496350502.SGD","JNJ","SG9999017495.SGD","LU1868837300.USD","LU1366192091.USD","LU1732800096.USD","LU0345769128.USD","LU0820561909.HKD","LU1883839398.USD","BK4592","LU0170899867.USD","LU0672654240.SGD","LU1917777945.USD","LU2237443895.HKD","LU1069344957.HKD","IE00BWXC8680.SGD","LU2087625088.SGD","LU1804176565.USD","LU0006306889.USD","LU2417539215.USD","BK1161","LU0889566641.SGD","CHAU","LU2361044865.SGD","LU0323591593.USD","SGXZ31699556.SGD","LU1323610961.USD","LU1935042991.SGD","KWEB","BK4532","CWEB","ASHS","DRAG","LU0234570918.USD","IE0004445015.USD","LU0238689110.USD","LU1232071149.USD","HXC","SG9999001176.SGD","LU0820561818.USD","LU0316494557.USD","LU2430703251.USD","LU1814569148.SGD","LU1506573853.SGD","LU1551013342.USD","LU1074936037.SGD","LU2347655156.SGD","BK4516","IE00BFTCPJ56.SGD","LU0097036916.USD","GB00BDT5M118.USD","IE00B7SZLL34.SGD","IE00BJJMRY28.SGD","IE00BJJMRZ35.SGD","LU0345770993.USD","LU0795875086.SGD","IE00B775H168.HKD","LU0795875169.SGD","LU1267930813.SGD","LU1585245621.USD","SG9999015952.SGD","LU1712237335.SGD","LU2129689605.HKD","LU1674673691.USD","LU1974910355.USD","LU0345770308.USD","LU2456880835.USD","SG9999018857.SGD","BK4559","IE00BKVL7J92.USD","CQQQ","LU1623119135.USD","LU2357305700.SGD","LU1868836757.USD","LU2133065610.SGD","LU1894683348.USD","IE0005OL40V9.USD","LU1093756325.SGD","LU0792757196.USD","LU0882574139.USD","LU0234572021.USD","LU0225771236.USD","LU0354030438.USD","LU0385154629.USD","LU1064131342.USD","BK4533","SG9999015945.SGD","LU0786609619.USD","LU1032466523.USD","LU0096364046.USD","IE00BKDWB100.SGD","LU2063271972.USD","LU1066051498.USD","IE00BDGV0183.EUR","LU0266013472.USD","BK4550","LU2552382058.USD","LU0198837287.USD","LU0882574055.USD","SG9999015986.USD","LU0640476718.USD","SG9999018865.SGD","LU1983299246.USD","LU1430594728.SGD","IE00B3PB1722.GBP","LU0353189763.USD","LU1162221912.USD","IE00BJT1NW94.SGD","SG9999014898.SGD","IE00BFSS8Q28.SGD","LU0689472784.USD","LU1267930730.SGD","LU1720051108.HKD","IE000M9KFDE8.USD","LU2264538146.SGD","SG9999014914.USD","LU0058720904.USD","SG9999001176.USD","LU2468319806.SGD","LU2491050071.SGD","LU0306806265.USD","LU1894683264.USD","LU2552382215.SGD","LU0114720955.EUR","LU0471298777.SGD","LU1989771016.USD","LU1127390331.HKD","LU0225284248.USD","LU2237438978.USD","LU0106261372.USD","BK4007","IE00B3T34201.USD","LU1196500208.SGD","IE00BJLML261.HKD","LU1548497426.USD","LU2746668461.USD","LU2592432038.USD","LLY","LU0943347566.SGD","LU1732799900.SGD","SGXZ99366536.SGD","LU0320765059.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","LU2211815571.USD","LU0061475181.USD","LU0306807586.USD","LU0456855351.SGD","LU2108987350.USD","LU2129689514.USD","LU2168564149.EUR","LU1914381329.SGD","LU2602419157.SGD","LU1868837136.USD","BK4614","IE00BSNM7G36.USD","SG9999002232.USD","LU0889565916.HKD","IE00BN8TJ469.HKD","LU1023059063.AUD","LU1778281490.HKD","LU1066051811.HKD","SG9999002224.SGD","SGXZ81514606.USD","LU1066053197.SGD","ASHR","LU0912757837.SGD","LU2023250504.SGD","IE00BFXG1179.USD","LU1551013425.SGD","LU2237443465.HKD","LU1244550221.USD","LU0098860793.USD","LU2471134879.HKD","LU1261432733.SGD","LU2491049909.HKD","SG9999014906.USD","LU1988902786.USD","IE00B19Z3B42.SGD","LU1674673428.USD","LU2089984988.USD","LU2236285917.USD","SG9999015978.USD","IE00BN29S564.USD","LU0354030511.USD","IE00B19Z3581.USD","LU1221951129.SGD","LU0868494617.USD","LU1032955483.USD","LU2552382132.HKD","LU2324357040.USD","IE0034235303.USD","IE00BKPKM429.USD","IE00BZ1G4Q59.USD","IE00B1XK9C88.USD","LU1059921491.USD","BK4585","LU1868836914.USD","SG9999003800.SGD","LU2462157665.USD","LU1035775433.USD","LU0823416689.USD","BK4581","IE00BFSS7M15.SGD","LU2237443622.USD","IE0002270589.USD","LU0289739699.SGD","LU2750360641.GBP","LU2129689431.USD","IE00B42XCP33.USD","LU2505996509.AUD","SG9999001440.SGD","LU2430703095.HKD","LU0417517546.SGD","SG9999014880.SGD","LU0203345920.USD","LU0203347892.USD","IE00B4R5TH58.HKD","LU2361045086.USD","LU0203202063.USD","LU0109394709.USD","LU2430703178.SGD","BK4504","BK4534","LU0094547139.USD","LU2746668974.SGD"],"gpt_icon":1},{"id":"2589802971","title":"RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study","url":"https://stock-news.laohu8.com/highlight/detail?id=2589802971","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589802971?lang=en_us&edition=fundamental","pubTime":"2025-12-08 09:00","pubTimestamp":1765155600,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec. 8, 2025 First and only chemotherapy-free combination in the first-line setting to demonstrate an overall survival benefit versus osimertinibamong Asian patients.Results from 501 participants who self-identified as Asian in the MARIPOSA trial, showed those treated with amivantamab plus lazertinib had a 26 percent lower risk of death compared with osimertinib , based on a median follow-up of 38.7 months. MedianOSfor the combination was not yet reached compared with 38.4months for osimertinib . Survival projections suggest that amivantamab plus lazertinib could extend median OS to more than a year beyond that achieved with osimertinib. At three years, 61 percent of patients treated with the combination were alive compared with 53 percent of those receiving osimertinib. The survival advantage was maintained at 42 months, with survival rates of 59 percent and 46 percent,respec","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2771572/1298d71d_502d_4bb1_9019_512d4a14e9a7_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2771572/1298d71d_502d_4bb1_9019_512d4a14e9a7_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-delivers-statistically-significant-and-clinically-meaningful-improvement-in-overall-survival-benefit-for-asian-patients-with-egfr-mutated-non-small-cell-lung-cancer-in-the--302633939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","IE00B3T34201.USD","LU1674673691.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0345770308.USD","LU1732799900.SGD","SEER","LU0098860793.USD","LU1074936037.SGD","JNJ","IE00BJT1NW94.SGD","BK4534","LU2602419157.SGD","LU2505996509.AUD","BK4559","LU1894683348.USD","BK4585","IE00B19Z3581.USD","LU0345770993.USD","LU1929549753.HKD","LU2505996681.GBP","IE00BGHQF631.EUR","LU1066051225.USD","ORR.AU","LU2129689431.USD","LU2129689514.USD","IE00BLSP4452.SGD","BK4581","OS","LU0058720904.USD","LU0466842654.USD","IE00B1BXHZ80.USD","BK4550","LU0345769631.USD","LU1267930813.SGD","LU2089984988.USD","LU2468319806.SGD","LU0203347892.USD","LU0912757837.SGD","BK4195","ORR","IE00B19Z3B42.SGD","LU1778281490.HKD","PFS","LU2592432038.USD","BK4504","IE00B3PB1722.GBP","LU1261432733.SGD","LU1162221912.USD"],"gpt_icon":0},{"id":"2589882698","title":"Johnson & Johnson Reports CARVYKTI Achieves 80% Treatment-Free Remission at 2.5 Years in Multiple Myeloma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589882698","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589882698?lang=en_us&edition=fundamental","pubTime":"2025-12-06 22:30","pubTimestamp":1765031425,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced updated results from the Phase 3 CARTITUDE-4 clinical study evaluating CARVYKTI  in patients with relapsed or refractory multiple myeloma. The data, already presented, demonstrate that at least 80 percent of as-treated standard-risk patients remained progression-free and did not require further treatment 2.5 years after a single infusion of CARVYKTI administered as early as second-line therapy. The company highlighted that stronger immune fitness in earlier lines of treatment may be associated with longer progression-free survival. CARVYKTI is approved in the U.S. and Europe for adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor, an immunomodulatory agent, and are refractory to lenalidomide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDL5bqsGz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","IE00BZ1G4Q59.USD","LU0432979614.USD","IE00B1BXHZ80.USD","LU2471134879.HKD","LU2430703251.USD","IE00BJT1NW94.SGD","IE00B3T34201.USD","LU0985320562.USD","IE00B4R5TH58.HKD","LU2750360997.AUD","IE00BSNM7G36.USD","LU0234570918.USD","LU1267930813.SGD","BK4581","IE00BVYPNW00.USD","BK4532","IE0002270589.USD","LU1718418525.SGD","LU1732799900.SGD","LU1059921491.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU2505996681.GBP","SG9999001440.SGD","LU1066051811.HKD","BK4588","LU1066051498.USD","LU1778281490.HKD","LU1929549753.HKD","LU2471134952.CNY","IE00B3PB1722.GBP","IE00BBT3K403.USD","SG9999002232.USD","IE00BDGV0183.EUR","LU1280957306.USD","JNJ","LU0345769128.USD","LU0640476718.USD","LU0345769631.USD","LU1032466523.USD","LU1066051225.USD","BK4534","LU0122379950.USD","LU1032955483.USD","LU1894683348.USD","LU1261432733.SGD","LU0882574055.USD","LU1244550221.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2589810089","title":"Johnson & Johnson Posts 74% One-Year Disease-Free Survival Rate in INLEXZO Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810089","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589810089?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:53","pubTimestamp":1764971628,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  reported late Friday data from Cohort 4 of the SunRISe-1 study, which is testing its investigational drug INLEXZO.At one year, the gemcitabine intravesical system, used to treat patients with Bacillus Calmette-Guerin-unresponsive, high-risk, papillary-only non-muscle invasive bladder cancer, showed high disease-free survival rate of 74%.The Phase 2b trial also indicated over 95% of patients remained progression free and around 92% did not undergo bladder removal.The investigational drug therapy was well-tolerated, with mild urinary side effects.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0345770993.USD","LU1935042991.SGD","JNJ","IE00B3PB1722.GBP","LU1059921491.USD","IE00BBT3K403.USD","LU2505996681.GBP","LU0345769631.USD","IE000M9KFDE8.USD","IE00BDGV0183.EUR","LU1914381329.SGD","LU0070217475.USD","LU2471134952.CNY","IE00BN8TJ469.HKD","LU0882574055.USD","LU1244550494.USD","LU1732799900.SGD","IE00BJT1NW94.SGD","LU1894683264.USD","IE00B1BXHZ80.USD","LU1894683348.USD","LU2089984988.USD","BK4532","LU2471134879.HKD","LU1066051498.USD","LU2602419157.SGD","LU1732800096.USD","LU1430594728.SGD","LU1280957306.USD","LU2129689605.HKD","IE00BFTCPJ56.SGD","BK4533","LU1074936037.SGD","LU1066053197.SGD","LU0122379950.USD","LU1244550577.SGD","LU1778281490.HKD","LU1718418525.SGD","LU0985320562.USD","IE00B7SZLL34.SGD","IE0002141913.USD","BK4559","IE00B42XCP33.USD","LU0345770308.USD","LU1057294990.SGD","LU1674673691.USD","LU2347655156.SGD","BK4581","IE00B4R5TH58.HKD","LU0640476718.USD"],"gpt_icon":0},{"id":"2589581055","title":"Johnson & Johnson Reports Positive Results for Gemcitabine Intravesical System in High-Risk NMIBC Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589581055","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589581055?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:20","pubTimestamp":1764969618,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has announced new data from Cohort 4 of the Phase 2b SunRISe-1 study evaluating the investigational gemcitabine intravesical system  in patients with Bacillus Calmette-Guérin -unresponsive, high-risk, papillary-only non-muscle invasive bladder cancer . The results, presented as a late-breaking oral presentation at the Society of Urologic Oncology  2025 Annual Meeting and previously at the 2025 American Urological Association  Annual Meeting, showed that treatment with the gemcitabine intravesical system achieved a 74 percent disease-free survival rate at one year. More than 95 percent of patients remained progression-free, and over 92 percent did not undergo bladder removal at one year. These findings support continued evaluation of the therapy in the ongoing Phase 3 SunRISe-5 study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL1RFj7y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689605.HKD","LU0889566641.SGD","LU1066053197.SGD","IE00BDGV0183.EUR","IE0034235303.USD","IE00BKVL7J92.USD","LU1066051225.USD","LU0466842654.USD","LU1032466523.USD","LU1244550221.USD","IE00BFXG1179.USD","LU2471134523.USD","JNJ","BK4550","LU1057294990.SGD","LU2347655156.SGD","LU0432979614.USD","LU1267930813.SGD","LU1162221912.USD","BK4585","LU1718418525.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU0114720955.EUR","LU1914381329.SGD","LU0345770308.USD","LU2129689431.USD","IE00BSNM7G36.USD","LU0912757837.SGD","LU2602419157.SGD","SG9999001440.SGD","LU1032955483.USD","LU2468319806.SGD","LU0203345920.USD","BK4532","LU1430594728.SGD","LU2750360997.AUD","LU0345769128.USD","SG9999002224.SGD","LU0882574055.USD","IE00BGHQF631.EUR","SG9999002232.USD","BK4568","IE0002141913.USD","LU1674673691.USD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU2592432038.USD","BK4534","LU1023059063.AUD"],"gpt_icon":0},{"id":"2589810300","title":"Johnson & Johnson's Inlexzo™ (Gemcitabine Intravesical System) Delivers 74 Percent Disease-Free Survival at One Year in Bcg-Unresponsive, High-Risk, Papillary-Only Nmibc","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589810300?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:20","pubTimestamp":1764969604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B42XCP33.USD","LU0912757837.SGD","IE00BFXG1179.USD","IE00BN8TJ469.HKD","LU1914381329.SGD","LU2505996681.GBP","LU1221951046.USD","LU1894683264.USD","IE00B7SZLL34.SGD","LU1894683348.USD","LU1066051225.USD","LU0320765646.SGD","LU0114720955.EUR","IE00BSNM7G36.USD","LU1032466523.USD","LU1778281490.HKD","LU0466842654.USD","LU0203345920.USD","BK4532","BK4550","LU0640476718.USD","LU2129689514.USD","IE00BZ1G4Q59.USD","JNJ","LU1162221912.USD","IE00BVYPNV92.GBP","LU1280957306.USD","LU2602419157.SGD","SG9999001440.SGD","BK4533","IE00BFTCPJ56.SGD","LU2750360997.AUD","LU1221951129.SGD","LU0345770993.USD","LU1244550221.USD","LU0070217475.USD","IE00BJJMRZ35.SGD","LU1732799900.SGD","LU1244550577.SGD","IE0002270589.USD","LU1066051498.USD","LU0234570918.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","IE00BJT1NW94.SGD","BK4504","LU1718418525.SGD","IE00B19Z3581.USD","LU1066051811.HKD","LU1244550494.USD"],"gpt_icon":0},{"id":"2589998818","title":"Johnson & Johnson Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2589998818","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589998818?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:07","pubTimestamp":1764943620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JNJ/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2025 09:07 ET (14:07 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2589489129","title":"Guggenheim Adjusts Price Target on Johnson & Johnson to $227 From $206, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2589489129","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589489129?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:42","pubTimestamp":1764934973,"startTime":"0","endTime":"0","summary":"Johnson & Johnson (JNJ) has an average rating of overweight and mean price target of $207.41, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JNJ"],"gpt_icon":0},{"id":"2588506488","title":"Perrigo Co. PLC Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588506488","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588506488?lang=en_us&edition=fundamental","pubTime":"2025-12-03 06:34","pubTimestamp":1764714840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slipped 1.73% to $13.61 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.25% to 6,829.37 and the Dow Jones Industrial Average  rising 0.39% to 47,474.46.Perrigo Co. PLC closed 56.00% below its 52-week high of $30.93, which the company reached on March 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.04% to $205.42, Procter & Gamble Co.  fell 1.07% to $145.86, and Abbott Laboratories  fell 1.32% to $126.32.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1280957306.USD","IE00BDGV0183.EUR","LU1221951129.SGD","LU2129689514.USD","LU2592432038.USD","SG9999014575.USD","BK4592","LU1162221912.USD","SGXZ23171101.USD","ABT","IE00BJT1NW94.SGD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0124676726.USD","LU0203347892.USD","LU0289739699.SGD","LU1066053197.SGD","LU1989763427.SGD","LU2468319806.SGD","IE0034235303.USD","SG9999001440.SGD","LU1032955483.USD","LU0889566641.SGD","PRGO","JNJ","IE00B4R5TH58.HKD","LU0792757196.USD","LU2089984988.USD","GB00BDT5M118.USD","LU1989763690.USD","LU1894683348.USD","LU2129689605.HKD","LU1261432733.SGD","LU0640476718.USD","LU1059921491.USD","LU1032466523.USD","SG9999004303.SGD","IE00BJJMRZ35.SGD","IE00B1XK9C88.USD","LU0868494708.USD","IE00B7SZLL34.SGD","LU1066051498.USD","BK4558","PG","LU1196500208.SGD","LU0466842654.USD","LU2129689431.USD","LU0323591593.USD","BK4585"],"gpt_icon":0},{"id":"2588906346","title":"Johnson & Johnson wins European Commission approval for IMAAVY (nipocalimab) in generalized myasthenia gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2588906346","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588906346?lang=en_us&edition=fundamental","pubTime":"2025-12-03 03:32","pubTimestamp":1764703956,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has received European Commission approval for IMAAVY , a new FcRn-blocking monoclonal antibody, as an add-on to standard therapy for the treatment of generalised myasthenia gravis . This approval covers a broad population, including adults and adolescents aged 12 and older who are anti-acetylcholine receptor  or anti-muscle-specific kinase  antibody-positive. Nipocalimab is the first FcRn blocker approved for both adult and adolescent gMG patients in Europe, and is already approved in the U.S., Brazil, and Japan for this indication. The decision is supported by data from phase 2/3 clinical studies demonstrating sustained disease control and favorable tolerability in both adult and adolescent populations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLNjXqY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051225.USD","LU0098860793.USD","LU0882574055.USD","LU1162221912.USD","LU2347655156.SGD","LU1929549753.HKD","LU0320765646.SGD","LU1032466523.USD","LU2471134796.USD","IE00B19Z3B42.SGD","LU1244550577.SGD","IE00BFXG1179.USD","LU0640476718.USD","IE00BDGV0183.EUR","LU1674673428.USD","IE00B19Z3581.USD","LU1066051498.USD","LU1221951046.USD","LU1244550221.USD","LU1196500208.SGD","BK4588","IE00BZ1G4Q59.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU2471134952.CNY","LU0985320562.USD","IE0034235303.USD","BK4592","LU0122379950.USD","LU1732800096.USD","LU1778281490.HKD","JNJ","IE00BJT1NW94.SGD","LU2471134523.USD","LU1061106388.HKD","SG9999001440.SGD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","LU1023059063.AUD","LU1894683264.USD","LU1059921491.USD","LU2471134879.HKD","LU1496350502.SGD","LU1221951129.SGD","IE00BSNM7G36.USD","IE0002141913.USD","IE00B3T34201.USD","LU1032955483.USD","LU2592432038.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":199,"code":"91000000","status":"200"}]}}